Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001171843-22-001628
Filing Date
2022-03-04
Accepted
2022-03-03 18:57:39
Documents
110
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A f20fa_030322.htm 20-F/A 694567
2 EXHIBIT 12.1 exh_121.htm EX-12.1 7437
3 EXHIBIT 12.2 exh_122.htm EX-12.2 7317
4 EXHIBIT 13.1 exh_131.htm EX-13.1 5697
5 EXHIBIT 13.2 exh_132.htm EX-13.2 5680
6 EXHIBIT 15.1 exh_151.htm EX-15.1 3022
  Complete submission text file 0001171843-22-001628.txt   5425094

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ptgef-20210331.xml EX-101.INS 1081966
8 XBRL SCHEMA FILE ptgef-20210331.xsd EX-101.SCH 113887
9 XBRL CALCULATION FILE ptgef-20210331_cal.xml EX-101.CAL 70154
10 XBRL DEFINITION FILE ptgef-20210331_def.xml EX-101.DEF 232400
11 XBRL LABEL FILE ptgef-20210331_lab.xml EX-101.LAB 421633
12 XBRL PRESENTATION FILE ptgef-20210331_pre.xml EX-101.PRE 367571
Mailing Address 6 ADELAIDE ST. EAST SUITE 300 TORONTO A6 M5C 1H6
Business Address 6 ADELAIDE ST. EAST SUITE 300 TORONTO A6 M5C 1H6 416-737-7600
PORTAGE BIOTECH INC. (Filer) CIK: 0001095435 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 20-F/A | Act: 34 | File No.: 001-40086 | Film No.: 22711205
SIC: 1311 Crude Petroleum & Natural Gas